ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc. (ORIC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ORIC · as of Sep 30, 2025
Ownership Breakdown
156
Institutional Holders
▲ 10 vs Q2
$1.28B
Total Inst. Value
▲ $330.25M vs Q2
103.52M
Shares Outstanding
freeFloat 47.05%
106.49M
13F Shares Held
▲ 13.13M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ORIC largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
NEXTECH INVEST, LTD. pharmaceutical preparations | 7.16M | 9.17% | 9.17% | $85.95B | Nov 14, 2025 | — held |
ECOR1 CAPITAL, LLC pharmaceutical preparations | 6.73M | 8.61% | 8.61% | $80.74B | Nov 14, 2025 | ▲ 5.11M |
VR ADVISER, LLC pharmaceutical preparations | 6.60M | 8.44% | 8.44% | $79.16B | Nov 14, 2025 | — held |
VIKING GLOBAL INVESTORS LP pharmaceutical preparations | 6.57M | 8.41% | 8.41% | $78.87B | Nov 14, 2025 | — held |
PFIZER INC pharmaceutical preparations | 5.38M | 6.88% | 6.88% | $64.52B | Nov 13, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 5.28M | 6.75% | 6.75% | $63.32B | Nov 12, 2025 | ▲ 1.20M |
VANGUARD GROUP INC pharmaceutical preparations | 4.65M | 5.95% | 5.95% | $55.80B | Nov 7, 2025 | ▲ 1.53M |
SR ONE CAPITAL MANAGEMENT, LP pharmaceutical preparations | 4.51M | 5.78% | 5.78% | $54.18B | Nov 12, 2025 | — held |
ALKEON CAPITAL MANAGEMENT LLC pharmaceutical preparations | 4.50M | 5.77% | 5.77% | $54.05B | Nov 14, 2025 | — held |
NEA MANAGEMENT COMPANY, LLC pharmaceutical preparations | 4.12M | 5.27% | 5.27% | $49.42B | Nov 14, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
28
Increased
+16.09M shares1
New Positions
first time holders9
Decreased
−1.45M shares0
Sold Out
fully exitedNet shares change (top 50)
+14.64M
+16.09M / −1.45M
Net new holders
+20
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ORIC insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
12
Buy transactions
4
Sell transactions
3.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Piscitelli Dominic Chief Financial Officer | Feb 24, 2026 | Sale | 52,000 | $13.51 | $702.7K | 68.1K | Form 4 ↗ |
Heyman Richard A. director | Jan 16, 2026 | Sale | 3,200 | $12.00 | $38.4K | 213.1K | Form 4 ↗ |
Heyman Richard A. director | Jan 16, 2026 | Sale | 3,500 | $12.00 | $42.0K | 41.8K | Form 4 ↗ |
You Angie director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Kunkel Lori Anne director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Hoerter Steven L. director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Heyman Richard A. director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Dier Mardi director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Piscitelli Dominic Chief Financial Officer | Jan 2, 2026 | Award | 206,500 | $8.17 | $1.69M | 206.5K | Form 4 ↗ |
Multani Pratik S Chief Medical Officer | Jan 2, 2026 | Award | 214,000 | $8.17 | $1.75M | 214.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
ORIC Pharmaceuticals, Inc. (ORIC) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 52.95%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of ORIC Pharmaceuticals, Inc. is NEXTECH INVEST, LTD., holding approximately 7.16 million shares — equal to 9.17% of outstanding shares — as of September 30, 2025.
A total of 156 institutional investors currently hold ORIC stock, with a combined institutional value of approximately $1.28 billion as of the most recent 13F filing period.
Frequently asked questions
ORIC ownershipORIC Pharmaceuticals, Inc. (ORIC) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is NEXTECH INVEST, LTD. with a 9.17% stake. Company insiders hold 52.95%. Data sourced from SEC Form 13F as of September 30, 2025.